Yahoo Web Search

  1. Additionally, Nevro faces stiff competition in the SCS market from MedTech bigwigs like Medtronic MDT, Boston Scientific and Abbott Laboratories ABT, who have already obtained ...

  2. NASDAQ: ANGO)' Cyclerion Therapeutics Inc (NASDAQ: CYCNV)(spun off from Ironwood Pharmaceuticals, Inc. NASDAQ: IRWD) GENFIT S.A. (NASDAQ: GNFT) Masimo Corporation (NASDAQ: MASI ...

  3. Abbott Laboratories’ ABT Medical Devices business has been gaining momentum on the back of solid sub-segmental performance. Abbott’s Medical Devices segment presently comprises ...

  4. Will Abbott's (ABT) Steady Overall Growth Aid Q1 Earnings?

    Zacks via Yahoo FinanceApr 15 12:35 PM

    Abbott Laboratories ABT is slated to report first-quarter 2019 results on Apr 17, before the market opens. In the last reported quarter, the company’s earnings per share of 81 ...

  5. Analyst Note Fosters Doubts About Dow Inc Stock

    InvestorPlace via Yahoo FinanceApr 10 15:00 PM

    Shares of the now-independent Dow Inc (NYSE:DOW) declined on Friday for the first time since the company was spun off . In his report, he noted that DOW has a higher dividend than its peers.

  6. Global chemical giants DowDuPont Inc. and BASF SE are investing millions to ramp up production of an indigestible sugar found naturally in breast milk. Infant formula makers like Nestle ...

  7. Muscular Dystrophy Association, or MDA, Clinical & Scientific Conference - April 13-17, at the Hyatt Regency in Orlando 29th European Congress of Clinical Microbiology & Infectious Diseases, ...

  8. Abbott Laboratories ABT reported first-quarter 2019 adjusted earnings from continuing operations of 63 cents per share, beating the Zacks Consensus Estimate by 3.3%. First-quarter ...

  9. Abbott Labs quarterly beat overshadowed by unchanged forecast

    Reuters via Yahoo FinanceApr 17 16:21 PM

    Abbott Laboratories Inc reported higher-than-expected quarterly profit and sales on surging demand for its glucose monitoring device, but an unchanged forecast along with ...

  10. AbbVie: High-Yield Dividend Aristocrat Offering a No-Fee DRIP

    GuruFocus.com via Yahoo FinanceApr 05 21:08 PM

    Dividend growth investing has proven to be one of the best ways for retail investors to accumulate wealth over the long term. One of the factors that boosts the wealth-creating power of dividend ...

  1. Ads
    related to ABBOTT LABORATORIES, INC